ClinicalTrials.Veeva

Menu

Tubeless VATS for Peripheral Lung Nodule

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Solitary Pulmonary Nodule

Treatments

Procedure: VATS without chest tube placement
Device: chest tube
Procedure: VATS with chest tube placement

Study type

Interventional

Funder types

Other

Identifiers

NCT02817048
201603030RIND

Details and patient eligibility

About

Chest tube placement after thoracoscopy surgery had been generally accepted as routine procedure for removal of the residual intrapleural fluid and air, however, it would cause post-operative pain, prohibit ambulation after surgery, and prolong the hospital stay. According to the recent studies, omission of chest tube placement after minor thoracoscopic procedures (such as pulmonary wedge resection) had been safe and feasible, and it also reduced the post-operative pain and shortened the hospital stay. We will conduct a prospective randomized trial in National Taiwan University Hospital.

Full description

We will enroll 100 patients with peripheral lung nodule who will be randomly assigned to no chest tube placement (tubeless group) or chest tube placement (control group) after thoracoscopic wedge resection with out without lymph adenectomy. The primary endpoints are to compare the post-operative hospital stay and post-operative pain sale between the two groups. The secondary endpoints are to compare the intercostal neuralgia and wound satisfaction one month after surgery between the two groups.

Enrollment

100 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CT revealed peripheral lung nodule, with both size and depth less than 2 cm
  • Aged 20 to 80 years

Exclusion criteria

  • Patients with ventilatory defect
  • Previous ipsilateral thoracic surgery
  • Bleeding tendency or anticoagulant use
  • Comorbidity including congestive heart failure, liver cirrhosis, chronic renal disease
  • Pregnancy or breast feeding
  • Immunocompromised or long-term steroid use
  • Severe infected patient
  • Patient who can not sign permit

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Tubeless
Active Comparator group
Description:
Interventions: VATS without chest tube placement
Treatment:
Procedure: VATS without chest tube placement
Chest tube
Active Comparator group
Description:
VATS with chest tube placement
Treatment:
Device: chest tube
Procedure: VATS with chest tube placement

Trial contacts and locations

0

Loading...

Central trial contact

Jin-Shing Chen, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems